160 related articles for article (PubMed ID: 26218123)
1. The endocytic pathway and therapeutic efficiency of doxorubicin conjugated cholesterol-derived polymers.
Sevimli S; Sagnella S; Macmillan A; Whan R; Kavallaris M; Bulmus V; Davis TP
Biomater Sci; 2015 Feb; 3(2):323-35. PubMed ID: 26218123
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
[TBL] [Abstract][Full Text] [Related]
3. Amphiphilic Diblock Terpolymer PMAgala-b-P(MAA-co-MAChol)s with Attached Galactose and Cholesterol Grafts and Their Intracellular pH-Responsive Doxorubicin Delivery.
Wang Z; Luo T; Sheng R; Li H; Sun J; Cao A
Biomacromolecules; 2016 Jan; 17(1):98-110. PubMed ID: 26682643
[TBL] [Abstract][Full Text] [Related]
4. Well-defined cholesterol polymers with pH-controlled membrane switching activity.
Sevimli S; Inci F; Zareie HM; Bulmus V
Biomacromolecules; 2012 Oct; 13(10):3064-75. PubMed ID: 22917061
[TBL] [Abstract][Full Text] [Related]
5. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
[TBL] [Abstract][Full Text] [Related]
6. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
7. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
10. Integrin-targeted zwitterionic polymeric nanoparticles with acid-induced disassembly property for enhanced drug accumulation and release in tumor.
Huang P; Song H; Wang W; Sun Y; Zhou J; Wang X; Liu J; Liu J; Kong D; Dong A
Biomacromolecules; 2014 Aug; 15(8):3128-38. PubMed ID: 25054812
[TBL] [Abstract][Full Text] [Related]
11. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
[TBL] [Abstract][Full Text] [Related]
12. Functionalizing biodegradable dextran scaffolds using living radical polymerization: new versatile nanoparticles for the delivery of therapeutic molecules.
Duong HT; Hughes F; Sagnella S; Kavallaris M; Macmillan A; Whan R; Hook J; Davis TP; Boyer C
Mol Pharm; 2012 Nov; 9(11):3046-61. PubMed ID: 23078353
[TBL] [Abstract][Full Text] [Related]
13. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
17. Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.
Liu J; Deng H; Liu Q; Chu L; Zhang Y; Yang C; Zhao X; Huang P; Deng L; Dong A; Liu J
Nanoscale; 2015 Mar; 7(10):4451-60. PubMed ID: 25679795
[TBL] [Abstract][Full Text] [Related]
18. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
19. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
Du H; Liu M; Yu A; Ji J; Zhai G
Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
[TBL] [Abstract][Full Text] [Related]
20. Polyanionic holothurian glycosaminoglycans-doxorubicin nanocomplex as a delivery system for anticancer drugs.
Mou J; Wu Y; Bi M; Qi X; Yang J
Colloids Surf B Biointerfaces; 2018 Jul; 167():364-369. PubMed ID: 29698785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]